Study on the development of nanotechnology in advanced countries and in Brazil

Abstract

The study shows how nanotechnology evolves in developed countries and Brazil, raising aspects of private and governmental initiatives. The investigation was based in scientific literature, electronic articles and conference reports. Several sources of literature were used, including electronic databases and reference lists. By this study, it was observed that, although nanotechnology is in initial stage of development all over the world, the developed countries have had growing public and private investments in the area each year. In those countries, there is a concern toward both, the formation of specialists in nanotechnology and the transference of technology developed in universities and research institutes to industry. In Brazil, the study showed that despite the growing concern of investigators, national research centers and financial centers toward the development of the nanotechnology, there is still a need for more investment and formation of area specialists.Uniterms: Nanotechnology/development. Nanobiotechnology. Nanopharmaceutical.O presente trabalho faz um estudo sobre o desenvolvimento da nanotecnologia, com enfoque na área de saúde, em países tecnologicamente mais avançados e no Brasil, levantando aspectos de iniciativas governamentais e privadas. A investigação foi baseada em literatura científica, artigos eletrônicos e relatórios de conferências. Foi observado que, apesar da nanotecnologia estar em estágio inicial no mundo inteiro, os países tecnologicamente mais avançados têm tido investimentos crescentes na área a cada ano, tanto públicos quanto privados. Há grande preocupação nesses países quanto à formação de profissionais especialistas na área e à transferência da tecnologia desenvolvida por universidades e institutos de pesquisa para a indústria. No Brasil, o estudo mostrou que apesar da crescente preocupação dos pesquisadores, centros de pesquisa e centros de financiamento com o desenvolvimento da nanotecnologia, ainda há necessidade de maiores investimentos e formação de profissionais especialistas na área.Unitermos: Nanotecnologia/desenvolvimento. Nanobiotecnologia. Nanofármaco.

Rozwój przemysłu w wybranych krajach (pdf)

“…Według szacunków w samym 2011 roku na rozwój nanotechnologii wydano na świecie około 5 mld dol., jednakże przewiduje się, że rynek materiałów przemysłowych, produktów i procesów opartych na nanotechnologii będzie wart w 2015 roku 1 bln dol. (Rediguieri, 2009) i znajdą one zastosowanie we wszystkich sektorach gospodarki jako technologia ogólnego przeznaczenia. Dodatkowo sektor ten będzie tworzyć nowe rodzaje działalności usługowych dla nanotechnologii oraz rozwijać inne przedsiębiorstwa związane z jej klastrowym charakterem (Menz, Ott, 2011).…”

“…5B). W Europie inicjatywy publiczne w dziedzinie badań w tym sektorze stanowią około 70,1%, podczas gdy w USA 35,7% (Rediguieri 2009). Według europejskich badań Lux Research and Spinverse (Crawley i in., 2012) rozwój NT w 50% finansowany jest z funduszy publicznych (udział ten wykazuje tendencję wzrostową), a w 46% przez firmy prywatne.…”

Patents, Drug Delivery and Public Health Protection: Health Risk Management for Nanopharmaceuticals

“…A critical difference between nanoparticles and particles of larger size is the ability to nanoparticles to move or translocate to different parts of the body (Rediguieri, 2009;Kosta and Bowman, 2010). There is evidence for the translocation of inhaled nanoparticles from the alveolar spaces into the interstitial, to local and regional lymph nodes, and into the circulatory system.…”

Nanomedicine for drug delivery in South Africa: a protocol for systematic review

“…Developed countries have taken a leading role in the field of nanomedicine as they are investing large amounts of money into developments in the technology [ 21 ]. For instance, many academic groups in Europe, Japan and the United States of America are leading nanomedicine research on delivery systems and clinical development of nanodrugs [ 22 ]. In Africa, nanomedicine is an emerging field, compared to the rest of the world, and the limiting factor for research is the cost of the required equipment [ 23 ].…”